-
MyChart
Log in to our secure, personalized website to manage your care (formerly myMDAnderson).
- Donate Today
This fall, officials with the Centers for Medicare and Medicaid Services (CMS) are debating the pros and cons of using low-dose CT scans to screen high-risk patients for early stage lung cancer, and whether to approve coverage for the screenings.
The decision may not be an easy one. It comes at a time in American medicine when experts are debating which tests are necessary and which are not. Last year, the United States Preventive...
MD Anderson scientists have discovered mutations in a gene that allow tumors to form and grow.
In this month’s issue of Cancer Cell...
Want to understand why cancer cells metastasize? Think of Sparta.
Ancient Greek warriors were fed a special diet that better prepared...
To speed the development of new cancer drugs, Bristol-Myers Squibb and MD Anderson are teaming up to conduct clinical trials of several new immunotherapy drugs that stimulate the body’s own immune system to fight cancer.
“Collaborations between industry and academia can offer a faster and broader spectrum of clinical trials to benefit patients,” said Hagop Kantarjian, M.D., chair of Leukemia at MD Anderson. “We hope innovative...
